RNXT

RenovoRx, Inc. RNXT

RNXT
RenovoRx, Inc. ABVC
ABVC BioPharma, Inc. INDP
Indaptus Therapeutics, Inc. KTTA
Pasithea Therapeutics Corp. BTTX
Better Therapeutics, Inc. FBRX
Forte Biosciences, Inc. VRPX
Virpax Pharmaceuticals, Inc. RNAZ
TransCode Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RNXT ABVC INDP KTTA BTTX FBRX VRPX RNAZ
6M 43.78 % 232.60 % -70.83 % -47.23 % -50.00 % 190.86 % -91.25 % 25.11 %
YTD -18.38 % 374.26 % -83.62 % -74.42 % 0.00 % -39.57 % -99.78 % -79.54 %
1Y 11.00 % 508.00 % -88.62 % -84.16 % -50.00 % 221.47 % -99.82 % -96.86 %
3Y -37.29 % -64.65 % -92.75 % -97.08 % -99.99 % -41.83 % -99.99 % -100.00 %
5Y -84.71 % -92.67 % -99.33 % -98.95 % -100.00 % -98.54 % -100.00 % -100.00 %
10Y -84.71 % -99.79 % -99.97 % -98.95 % -100.00 % -99.67 % -100.00 % -100.00 %
From the beginning -84.71 % -100.00 % -99.97 % -98.95 % -100.00 % -99.67 % -100.00 % -100.00 %

Dividend